Urologic Imaging

Which Imaging Study Best Evaluates Asymptomatic Unilateral Hydronephrosis in an Adult?

·
Which Imaging Study Best Evaluates Asymptomatic Unilateral Hydronephrosis in an Adult?

An adult patient undergoes an abdominal CT for an unrelated reason, and the report notes an incidental finding: moderate left-sided hydronephrosis. The patient feels perfectly fine, with no flank pain, fever, or changes in urination. The initial CT, not being a dedicated urologic study, couldn’t pinpoint the cause. You are now faced with the clinical question of how to proceed. This is a common scenario where the goal is to identify a potentially significant underlying cause without subjecting the patient to unnecessary tests or radiation. For this specific presentation, the American College of Radiology (ACR) rates Magnetic Resonance Urography (MRU) without and with IV contrast as Usually Appropriate.

Who Fits This Clinical Scenario?

This diagnostic workflow is designed for a specific patient profile: an adult who is entirely asymptomatic but has unilateral hydronephrosis discovered on a previous imaging study (like an ultrasound or a non-contrast CT). The “unknown cause” is key; if the prior study clearly showed a large obstructing stone or a mass, the workup would follow a different path.

This guidance applies if:

  • The patient is an adult.
  • The hydronephrosis is unilateral (affecting only one kidney).
  • The patient has no related symptoms, such as flank pain, hematuria, fever, or signs of urinary tract infection.
  • The cause of the hydronephrosis was not determined on the initial imaging study.

It is crucial to distinguish this from similar but distinct clinical situations. This article does not apply if the patient is symptomatic, as the urgency and differential diagnosis change. Likewise, if the patient has bilateral hydronephrosis or hydronephrosis in a solitary kidney, the concern for acute or impending renal failure is much higher, warranting a different approach. Finally, any hydronephrosis found in a pregnant patient is managed under a separate set of guidelines due to unique physiologic considerations and the need to avoid fetal radiation exposure.

What Diagnoses Are You Working Up in This Scenario?

In an asymptomatic adult with unilateral hydronephrosis, the workup aims to differentiate between benign, non-urgent conditions and those requiring intervention. The differential diagnosis is broad, ranging from congenital anomalies to malignancy.

Ureteropelvic Junction (UPJ) Obstruction: This is one of the most common causes of congenital urinary tract obstruction, but it can first become apparent or diagnosed in adulthood. It involves a functional or anatomic narrowing at the point where the renal pelvis joins the ureter, leading to poor drainage and dilation of the collecting system.

Extrinsic Compression: The ureter can be compressed from the outside by various structures. This can include a benign process like a crossing vessel at the UPJ, retroperitoneal fibrosis, or something more concerning like lymphadenopathy or a primary retroperitoneal tumor. The imaging study must provide excellent visualization of the structures surrounding the ureter.

Benign Ureteral Stricture: A narrowing of the ureter can result from prior inflammation, infection, impacted stones that have since passed, or previous surgery (iatrogenic injury). These strictures are often short-segment and may cause chronic, low-grade obstruction that remains asymptomatic for years.

Urothelial Malignancy: While less common, a primary tumor of the ureter or renal pelvis (urothelial carcinoma) is a critical diagnosis to exclude. These tumors can be subtle and may present only with the secondary sign of upstream hydronephrosis. They are a key reason why high-resolution imaging with contrast is necessary.

Non-obstructive Dilation: In some cases, the collecting system may be dilated without a true obstruction. This can be seen in conditions like congenital megacalyces or as a persistent change after a prior obstruction has resolved. Differentiating this from true obstruction is a primary goal of the workup.

Why Is MRU without and with IV contrast the Recommended Study for This Presentation?

The ACR designates MR Urography (MRU) without and with IV contrast as Usually Appropriate because it provides a comprehensive evaluation of both anatomy and function without using ionizing radiation. This is a significant advantage in an asymptomatic patient where the risk-benefit balance for radiation exposure is carefully considered.

MRU excels at characterizing the cause of obstruction. Its superior soft-tissue contrast can clearly delineate the ureteral wall, identify small intrinsic masses, and visualize surrounding retroperitoneal structures that might be causing extrinsic compression. The “with contrast” portion of the study is vital. Gadolinium-based contrast agents allow for dynamic, excretory-phase imaging. This functional component helps determine if the dilated system is truly obstructed by showing delayed excretion of contrast through the affected side, a hallmark of significant blockage. This dual anatomic and functional assessment is what makes MRU so powerful in this scenario.

Let’s consider the alternatives and why they are rated differently for this specific patient:

  • CT Urography (CTU) without and with IV contrast: This study is also rated Usually Appropriate and provides outstanding anatomic detail, especially for detecting small calcified stones. However, it involves a substantial radiation dose (ACR RRL ☢☢☢☢, 10-30 mSv). Given that MRU can answer the clinical question without radiation, it is often preferred in younger patients or when the suspicion for a stone is low.
  • US color Doppler kidneys and bladder retroperitoneal: Rated as May be appropriate, ultrasound is excellent for confirming the presence of hydronephrosis but often fails to identify the specific level or cause of obstruction, particularly in the mid-ureter, which is obscured by bowel gas. It is a good screening tool, but this scenario assumes hydronephrosis is already known, and the goal is now definitive characterization.
  • MAG3 renal scan: This nuclear medicine study is also Usually Appropriate. It is the gold standard for quantifying renal function and the degree of obstruction. However, it provides very limited anatomic information. It is often used as a follow-up test after an anatomic study like MRU or CTU has identified a potential UPJ obstruction, but it is less ideal as the initial characterization study.

What’s Next After MRU without and with IV contrast? Downstream Workflow

The results of the MRU will guide the subsequent clinical pathway, which typically involves a urology consultation. The next steps are contingent on the specific findings.

  • If the study is positive for a clear obstruction (e.g., UPJ obstruction, stricture): The patient should be referred to urology. The urologist will likely perform functional testing, such as a MAG3 renal scan with a diuretic (lasix renogram), to quantify the severity of the obstruction and determine if surgical intervention (e.g., pyeloplasty) is needed.
  • If the study identifies a suspicious mass (intrinsic or extrinsic): This finding requires urgent urologic or oncologic referral. Further management will depend on the location and appearance of the mass and may involve biopsy or surgical excision.
  • If the study is negative or shows non-obstructive dilation: If the MRU demonstrates a dilated but freely draining collecting system, it suggests non-obstructive caliectasis or a resolved prior obstruction. In these cases, a conservative approach is often taken. This may involve periodic monitoring with renal ultrasound and serum creatinine checks to ensure the condition remains stable and the patient does not develop symptoms or renal function decline.
  • If the study is indeterminate: Occasionally, the findings may be ambiguous. For example, there may be a question of a small, non-enhancing intraluminal filling defect. In such cases, the next step might be direct visualization with ureteroscopy, which allows for biopsy and definitive diagnosis.

Pitfalls to Avoid (and When to Get Help)

When investigating asymptomatic unilateral hydronephrosis, several common pitfalls can delay diagnosis or lead to unnecessary testing. First, avoid the temptation to simply repeat the initial, non-diagnostic imaging study (e.g., ordering another non-contrast CT). The goal is to advance the workup with a more definitive test. Second, do not order a standard MRI of the abdomen and pelvis; a dedicated MR Urography protocol with excretory phases is essential to evaluate the urinary tract properly. Third, remember to check renal function (eGFR) before ordering a contrast-enhanced MRU, as gadolinium-based contrast agents have specific safety considerations in patients with severe renal impairment. If the MRU report is equivocal or if you are uncertain about the clinical significance of the findings, a consultation with a urologist or the reporting radiologist is the appropriate next step.

Related ACR Topics and Tools

The ACR Appropriateness Criteria are a powerful resource for evidence-based imaging decisions. For a broader overview of all clinical variants related to this topic, please see our parent guide. For further exploration of imaging guidelines, protocols, and safety, the following GigHz resources are available.

Frequently Asked Questions

Why not just start with a CT Urogram (CTU) since it’s also rated ‘Usually Appropriate’?

While CTU is an excellent test, MR Urography (MRU) is often preferred in this specific scenario because it provides comparable diagnostic information without any ionizing radiation. In an asymptomatic patient, minimizing radiation exposure is a key consideration. MRU also offers superior soft-tissue contrast, which can be better for evaluating potential non-calcified causes like small tumors or extrinsic compression from soft tissue.

My patient has a gadolinium allergy. Can I still order an MRU?

Yes. An MRU without IV contrast is rated as ‘May be appropriate’. While it will not provide the functional information from excretory phases or show enhancement patterns of masses, it can still offer excellent anatomic detail without radiation. It can identify the level of obstruction and may reveal causes like crossing vessels or retroperitoneal masses. The decision between a non-contrast MRU and a CTU would then depend on the specific clinical suspicion and patient factors.

The initial finding was on an ultrasound. Is another ultrasound ever the right next step?

Generally, no. If the initial ultrasound confirmed hydronephrosis but could not determine the cause, repeating the same study is unlikely to yield new information. The purpose of the next imaging step is to characterize the cause and level of the blockage, which requires a cross-sectional study like MRU or CTU that can visualize the entire length of the ureter.

What if the patient develops flank pain or a fever while awaiting the MRU?

If the patient becomes symptomatic, their clinical scenario changes from ‘asymptomatic’ to ‘symptomatic hydronephrosis’. This increases the urgency of the workup. You should consult the ACR guidelines for symptomatic hydronephrosis, which may prioritize a faster or different imaging test (like CT) to look for acute causes like an obstructing stone or infection (pyonephrosis).

Is a nuclear medicine renal scan (MAG3 or DTPA) a good first choice?

A nuclear medicine scan is a functional study, not an anatomic one. It is excellent for answering the question ‘How severe is the obstruction?’ but poor at answering ‘What is causing the obstruction?’. Therefore, it is typically used after an anatomic study like MRU or CTU has been performed, especially if a UPJ obstruction is suspected and the surgeon needs to quantify its physiologic significance before planning an intervention.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026